Severe hypertriglyceridemia-related acute pancreatitis

Area of Science:

• Endocrinology
• Gastroenterology
• Metabolic Disorders

Background:

• Severe hypertriglyceridemia, defined by elevated triglyceride levels (>1000 mg/dL), is a critical risk factor for acute pancreatitis.
• Causes include inborn errors of metabolism and various clinical conditions leading to high levels of triglycerides, chylomicrons, and related lipoproteins.

Purpose of the Study:

• To review current evidence on managing acute pancreatitis associated with severe hypertriglyceridemia.
• To focus on symptoms, treatment strategies, and potential complications.

Main Methods:

• Review of international guidelines and existing literature on hypertriglyceridemia and acute pancreatitis management.
• Analysis of standard pharmacological treatments and non-pharmacological interventions.

Main Results:

• Standard therapies include lipid-lowering agents, heparin, and insulin for diabetic patients.
• Therapeutic plasma exchange is an effective non-pharmacological option when medical therapies are insufficient.
• Plasma exchange significantly reduces triglyceride levels during acute phases and aids in preventing recurrence.

Conclusions:

• Acute pancreatitis in severe hypertriglyceridemia requires prompt management.
• Therapeutic plasma exchange is a valuable adjunctive therapy for severe hypertriglyceridemic pancreatitis.
• Effective management is crucial for reducing morbidity and mortality.